Robot IPO Soars 542% 🤖 32 China-US Pharma Deals 💊 26,000km Border Road Planned 🛣️

2026-08-24 | subscribe | homepage

Welcome back to China Insights Weekly. Here are some of the key highlights for this week’s edition:

• Alibaba models pass 3 billion downloads, overtaking Meta and Google on Hugging Face

• LandSpace recovers a rocket stage on land, advancing China’s reusable-launch ambitions

• Digital yuan expands to 30 banks, with RMB 16.7 trillion already transacted

• Visa-free transit reaches 57 countries, adding Kyrgyzstan and Vietnam

Remember to follow us on LinkedIn, X or Facebook.

🚀 Headlines

Chinese humanoid robots smash human records in 100m sprint and high jump, Unitree IPO pops 542% (link, link)

More than 2,000 humanoid robots competed in Beijing's five-day World Humanoid Robot Games. A robot ran 100 meters in 9.39 seconds, beating Usain Bolt's human record of 9.58 seconds. Another cleared 2.88 meters in the standing high jump, surpassing the human record of 2.45m. The event featured 51 disciplines and over 1,000 competitions. It coincided with Beijing's World Robot Conference, which showcased roughly 3,000 products.

Unitree Robotics' shares surged 542% on its Shanghai STAR Market debut on August 19, closing at 845 yuan after hitting an intraday peak of 1,100 yuan. The Hangzhou-based humanoid robot maker raised approximately 6.1 billion yuan (USD 905 million) in its IPO. DeepSeek invested about 140.8 million yuan in the offering. The company unveiled a new humanoid robot, "Superman," capable of jumping two metres from a standing position and running at 12.66 metres per second. Unitree is the latest Chinese tech name to hit the STAR Market, following memory chipmaker CXMT's 466% first-day surge last month. Morgan Stanley forecasts China's humanoid robot market will grow from USD 2 billion this year to USD 15 billion by 2030.

The US and China pharma pipeline growth accelerates with 32 deals in 2026 (link)

US and Chinese drugmakers have struck 32 licensing deals through July, putting 2026 on track to surpass last year's record of 45, according to Bloomberg Intelligence. For US firms, the appeal is clear: "twice as fast at half the cost in China." The stakes are asymmetric: Chinese-origin drugs comprise 40-50% of the global pipeline, while US licensing fees have become a lifeline for Chinese firms facing a 70% drop in venture funding from its 2021 peak. Chinese companies accounted for nearly half of global pharma licensing value in 2025.

Clariant launches two new R&D laboratories in China, strengthening local innovation capability (link)

Clariant inaugurated two additives R&D laboratories in Dayawan, Huizhou and Shanghai on August 18, completing a local closed-loop from R&D to pilot-scale production for flame retardants and high-performance additives. The Dayawan site, which commenced production in 2023 and expanded in November 2025, represents a total investment of CHF 100 million. The new labs are equipped with atmospheric and high-pressure synthesis reactors, TGA, DSC, XRF, GC and ion chromatography. Clariant has now built a complete local innovation chain in China spanning R&D, manufacturing and partnerships, which will shorten lead times and accelerate technical support.

LandSpace achieves China’s first land-based rocket recovery (link)

China successfully recovered the first stage of a Zhuque-3 Y2 rocket on land on August 18, its first such feat using landing legs. The orbital-class booster touched down in Minqin county, Gansu, after a pre-programmed descent involving attitude adjustments and re-entry burns. The mission, by developer LandSpace, follows a sea recovery in July. Recovering the first stage, which accounts for over 70% of a rocket's cost, is key to reusability.

Alibaba AI models hit 3 billion downloads, passing Google, Meta (link)

Alibaba's open-weight AI models surpassed 3 billion global downloads in the past six months, eclipsing Meta (227 million) and Google (418 million) on HuggingFace's leading open-source hub. Qwen has open-sourced over 460 models, spawning more than 300,000 derivatives. Chinese models now carry over 60% of OpenRouter's traffic, up from 30% a year ago, processing more than 20 trillion tokens weekly. US firms account for a record 58% of that Chinese-model token volume, driven by price-performance: DeepSeek V4-Flash costs USD 0.14 per million input tokens versus USD 5.00 for GPT-5.5. Alibaba released the compact Qwen3.8-27B for local devices and published weights for Qwen3.8-Max, consolidating its lead over Meta's open-source initiative.